The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Official Title: Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Study ID: NCT00901732
Brief Summary: Patients who have been diagnosed with a head and/or neck cancer commonly develop oral mucositis (OM). The purpose of this study is to estimate the effect of Caphosol on OM and to evaluate if Caphosol had any effect on clinical outcomes which include quality of life, oral intake, swallowing function and pain.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
University of Florida College of Medicine, Gainesville, Florida, United States
H. Lee Moffitt Cancer Center, Tampa, Florida, United States
Beth Israel Medical Center, New York, New York, United States
Duke University Medical Center, Durham, North Carolina, United States
Temple University Hospital, Philadelphia, Pennsylvania, United States
MD Anderson Cancer Center, Houston, Texas, United States
Name: Andy M Trotti, MD
Affiliation: Moffitt Cancer Center, Tampa Florida
Role: PRINCIPAL_INVESTIGATOR
Name: David M Brizel, MD
Affiliation: Duke University, Durham, North Carolina
Role: STUDY_DIRECTOR
Name: David I Rosenthal, MD
Affiliation: MD Anderson Cancer Center, Houston, Texas
Role: PRINCIPAL_INVESTIGATOR
Name: Mark Chambers, MD
Affiliation: MD Anderson Cancer Center, Houston, Texas
Role: STUDY_DIRECTOR
Name: Curtis T Miyamoto, MD
Affiliation: Temple University Hospital, Philadelphia, PA
Role: STUDY_DIRECTOR
Name: Kenneth Hu, MD
Affiliation: Beth Israel Medical Center, New York, New York
Role: STUDY_DIRECTOR
Name: Robert Amdur, MD
Affiliation: University of Florida, Gainesville, Florida
Role: STUDY_DIRECTOR